Former NHS CIO Will Smart Joins Alcidion

Alcidion LtdA former national chief information officer for health and social care in England, Will Smart will join the Alcidion Group board in a global role from October. He will provide strategic insight as the company continues to support healthcare organisations in different parts of the world digitise frontline services.

During an extensive career in digital health, Smart has advised senior government ministers, has played leading roles in initiatives including the Global Digital Exemplar programme and has helped to drive technology adoption from within the health technology industry.

Commenting on his new role with Alcidion, Will Smart said: "Alcidion continues to win really interesting projects, as healthcare systems work to advance digitisation. The company deserves mindshare from healthcare CIOs for its very impressive modern, interoperable, standards-based EPR platform, and for technologies now needed to address key issues such as how patients flow across systems. I look forward to sharing ideas and working closely with the Alcidion team, who have proven themselves to be thoughtful and committed in delivering the best possible products and outcomes for customers."

Smart is a former global director of external relations for Dedalus Group. He has also held executive roles at several NHS trusts during his career, including group chief information officer for the Royal Free London NHS Foundation Trust.

He will remain in post as digital non-executive director for Great Western Hospitals NHS Foundation Trust, from where he serves as a member of the Acute Hospitals Alliance EPR Joint Committee, which is responsible for overseeing the delivery of a shared EPR across three NHS trusts.

Smart remains a director of CareTech Partners Limited, which provides digital advisory and consultancy support. He is also a member of Health and Social Care Council at techUK, a trade association which represents and champions companies in the UK technology sector.

Kate Quirke, CEO for Alcidion, said: "Will's extensive experience in digitising frontline services will help to inform our strategic direction as we continue to serve more and more healthcare providers throughout the world, with genuine solutions to meet their needs. We look forward to inspiring and open discussions that will help to further enhance our effectiveness in this mission."

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 400 hospitals and 87 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...